Literature DB >> 7198157

Zinc and copper status of treated children with phenylketonuria.

P B Acosta, P M Fernhoff, H S Warshaw, K M Hambidge, A Ernest, E R McCabe, L J Elsas.   

Abstract

Children with phenylketonuria (PKU) are treated with semi-synthetic diets restricted in phenylalanine. Low or phenylalanine-free formulae provide the majority of protein and energy in the diet while phenylalanine requirements are met by low-protein natural foods. Because of the restriction of natural protein sources in this diet, the study assessed the zinc and copper nutriture of treated children with PKU and correlated linear growth with zinc status. The plasma zinc of the PKU population was 66.6 +/- 3.3 micrograms/dl (mean +/- SEM). The hair zinc was 70.2 +/- 11.5 micrograms/g (mean +/- SEM). The mean plasma and hair zinc of the PKU population were significantly different (p less than 0.05) when compared to normal values of 84.2 +/- 2.9 micrograms/dl and 130.7 +/- 8.3 micrograms/g (mean +/- SEM), respectively. The dietary zinc intake of 10 PKU patients was 8.56 +/- 2.68 mg/day (mean +/- SD). No significant differences (p less than 0.123) were found when the mean zinc intake was compared with recommended dietary allowances for age of 10 mg/day. No significant correlations were found when plasma and hair zinc were plotted with height percentiles. Plasma copper of the PKU subjects (87.6 +/- 6.6 micrograms/dl, mean +/- SEM) was significantly less than that of normal young children (121.5 +/- 3.1 micrograms/dl, mean +/- SEM) despite a copper intake a 1.45 +/- 0.35 mg/day (mean +/- SD).

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7198157     DOI: 10.1177/0148607181005005406

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  8 in total

1.  Treatment products and approaches for phenylketonuria: improved palatability and flexibility demonstrate safety, efficacy and acceptance in US clinical trials.

Authors:  A P Prince; M P McMurray; N R Buist
Journal:  J Inherit Metab Dis       Date:  1997-08       Impact factor: 4.982

2.  Trace elements nutriture in hyperphenylalaninemic patients. Long-term follow up study.

Authors:  R Longhi; A Rottoli; A Vittorelli; G Zecchini; T Bonabitacola; F Bertassi; E Riva; M Giovannini
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

3.  Plasma selenium levels in treated phenylketonuric patients.

Authors:  A Rottoli; G Lista; G Zecchini; C Butté; R Longhi
Journal:  J Inherit Metab Dis       Date:  1985       Impact factor: 4.982

4.  The management of breast feeding among infants with phenylketonuria.

Authors:  L McCabe; A E Ernest; M R Neifert; S Yannicelli; A M Nord; P J Garry; E R McCabe
Journal:  J Inherit Metab Dis       Date:  1989       Impact factor: 4.982

5.  Nutrition studies in treated infants and children with phenylketonuria: vitamins, minerals, trace elements.

Authors:  P B Acosta
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

6.  Evaluation of nutritional status and pathophysiology of growth retardation in patients with phenylketonuria.

Authors:  D Dobbelaere; L Michaud; A Debrabander; S Vanderbecken; F Gottrand; D Turck; J P Farriaux
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

7.  Problems related to diet management of maternal phenylketonuria.

Authors:  P B Acosta; S Stepnick-Gropper
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

8.  The effects of low protein products availability on growth parameters and metabolic control in selected amino acid metabolism disorders patients.

Authors:  Bedour Handoom; Eman Megdad; Dana Al-Qasabi; Munirah Al Mesned; Reem Hawary; Samir Al-Nufiee; Zuhair Al-Hassnan; Moeenaldeen Dia Alsayed; Abdelmoneim Eldali
Journal:  Int J Pediatr Adolesc Med       Date:  2018-06-14
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.